Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02600273 · ClinicalTrials.gov registry record · NA

Novel Approaches to Reducing Tobacco Related Harm

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT02600273 is a NA study that has completed, run by Duke University. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02600273, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

The purpose of this study is to assess initial reactions to alternative nicotine/tobacco products among smokers living with HIV.

Interventions

  • OTHER Usual brand cigarettes
  • OTHER Lower nicotine content cigarettes
  • OTHER Electronic cigarettes 1
  • OTHER Electronic cigarettes 2

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2017-01
Est. Completion 2019-06
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02600273

The ClinicalTrials.gov registry entry for NCT02600273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Usual brand cigarettes is the first listed.

NCT02600273 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02600273 about?

NCT02600273 is a clinical study titled "Novel Approaches to Reducing Tobacco Related Harm". The purpose of this study is to assess initial reactions to alternative nicotine/tobacco products among smokers living with HIV.

What is the current status of trial NCT02600273?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-01. Estimated completion is 2019-06.

What interventions are being tested in trial NCT02600273?

The interventions under investigation include: Usual brand cigarettes (OTHER), Lower nicotine content cigarettes (OTHER), Electronic cigarettes 1 (OTHER), Electronic cigarettes 2 (OTHER).

Who is sponsoring clinical trial NCT02600273?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.